Has Samantha Wideman, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $13,758 in general payments to Samantha Wideman, APRN across 610 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Samantha Wideman, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Samantha Wideman, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Samantha Wideman, APRN

Nurse Practitioner · Hot Springs, ARNPI 1952052243

Payments from drug & device makers

$13,758in general payments, 2019–2025

Across 610 payments — averaging $22.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pharmacosmos Therapeutics Inc.$2K
Novartis$1K
AstraZeneca$762
Exelixis Inc.$752
Pfizer$702
Johnson & Johnson$625
plus $8K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pharmacosmos Therapeutics Inc.	13	$1,994
Novartis	92	$1,313
AstraZeneca(2 entities)	31	$762
Exelixis Inc.	30	$752
Pfizer	41	$702
Johnson & Johnson(2 entities)	34	$625
Merck	32	$551
Eisai Inc.	19	$486
Incyte Corporation	20	$463
GSK	23	$432
AbbVie	18	$382
Takeda Pharmaceuticals U.S.A., Inc.	14	$367
Daiichi Sankyo Inc.	15	$337
Sanofi	13	$286
Bristol Myers Squibb	19	$253
Gilead	13	$241
Seagen Inc.	14	$230
Regeneron Healthcare Solutions, Inc.	8	$204
Lilly USA, LLC	11	$175
Bayer	8	$174
Morphosys, US Inc.	8	$151
Sobi, Inc	8	$150
Mirati Therapeutics, Inc.	7	$129
Amgen	9	$127
Otsuka America Pharmaceutical, Inc.	1	$125
Astellas Pharma US Inc	7	$112
Array Biopharma Inc	6	$111
Biohaven Pharmaceutical Holding Company Ltd.	1	$108
Karyopharm Therapeutics Inc.	1	$107
Sirtex Medical Inc	1	$105
E.r. Squibb & Sons, L.L.C.	6	$101
Beone Medicines USA, Inc.	5	$97
Beigene USA, Inc.	5	$97
Adaptive Biotechnologies Corporation	2	$96
Sanofi-aventis U.S. LLC	1	$95
AVEO Pharmaceuticals, Inc.	5	$80
Shield Therapeutics Inc	5	$79
Celltrion USA Inc.	4	$76
Stemline Therapeutics Inc.	4	$75
EMD Serono, Inc.	4	$74
Spectrum Pharmaceuticals Inc.	4	$72
Pharmacyclics LLC, An Abbvie Company	4	$65
Geron Corporation	3	$60
Myriad Genetic Laboratories, Inc.	3	$56
Pharmaessentia USA Corporation	3	$56
Ipsen Biopharmaceuticals, Inc	3	$55
Iovance Biotherapeutics, Inc.	2	$54
Dendreon Pharmaceuticals LLC	2	$53
Puma Biotechnology, Inc.	3	$50
Rigel Pharmaceuticals, Inc.	3	$46
Blueprint Medicines Corporation	2	$45
Boehringer Ingelheim	2	$40
Acrotech Biopharma Inc.	2	$33
CTI Biopharma Corp.	2	$32
Jazz Pharmaceuticals Inc.	2	$30
Genentech USA, Inc.	2	$27
G1 Therapeutics, Inc.	2	$26
Tersera Therapeutics LLC	1	$23
Apellis Pharmaceuticals, Inc.	1	$20
Heron Therapeutics, Inc.	1	$20

How this compares

$13,758 in reported general payments places this provider in the 95th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas →

Medicare billing

Part B allowed, 2024

$32,515

Medicare patients

152

Services billed

878

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Hot Springs

Tiffany McConathyHot Springs$54K
Virginia LaliberteHot Springs$21K
Cody WilliamsHot Springs$12K
Nan MeansHot Springs$7K
Ragan ArrisonHot Springs$7K
Laci PattonHot Springs$7K
Samantha BollanHot Springs$7K
Kayla HarringtonHot Springs$6K
Mindy FarmerHot Springs$5K
Kristyl WoolseyHot Springs$4K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →